Page last updated: 2024-11-11

hinokiresinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hinokiresinol: RN given for (S-(E))-isomer; inhibits binding of leukotriene B4 to neutrophils; structurein first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5377291
CHEMBL ID198245
SCHEMBL ID776219
MeSH IDM0306599

Synonyms (14)

Synonym
(+/-)-hinokiresinol
CHEMBL198245
rac-hinokiresinol
4-[(1e)-3-(4-hydroxyphenyl)penta-1,4-dienyl]phenol
hinokiresinol
SCHEMBL776219
(e)-hinokiresinol
an trans-hinokiresinol
phenol, 4,4'-(3-vinylpropenylene)di-, (e)-
VEAUNWQYYMXIRB-ZZXKWVIFSA-N
phenol, 4,4'-(3-ethenyl-1-propene-1,3-diyl)bis-, (e)-
4,4'-(1e)-penta-1,4-diene-1,3-diyldiphenol
AKOS032948662
4-[(3s)-1-(4-hydroxyphenyl)penta-1,4-dien-3-yl]phenol

Research Excerpts

Overview

Cis-Hinokiresinol (CHR) is a norlignan constituent from Anemarrhena asphodeloides BUNGE (Liliaceae) It shows hyaluronidase inhibitory activity.

ExcerptReferenceRelevance
"cis-Hinokiresinol (CHR) is a norlignan constituent from Anemarrhena asphodeloides BUNGE (Liliaceae), which shows hyaluronidase inhibitory activity. "( cis-hinokiresinol, a norlignan from Anemarrhena asphodeloides, inhibits angiogenic response in vitro and in vivo.
Higuchi, R; Jeong, SJ; Kim, YC; Kuwano, M; Miyamoto, T; Ono, M, 2003
)
1.44
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID661673Inhibition of DNP-BSA-induced degranulation in rat RBL2H3 cells assessed as reduction in beta-hexosaminidase release after 20 mins by spectrophotometry2012Bioorganic & medicinal chemistry letters, Jun-01, Volume: 22, Issue:11
Synthesis of norlignans and in vitro inhibitory activity of antigen-induced degranulation.
AID259061Antiplasmodial activity against Plasmodium falciparum 3D72006Journal of medicinal chemistry, Jan-12, Volume: 49, Issue:1
Antimalarial and antiplasmodial activities of norneolignans. Syntheses and SAR.
AID404154Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed after 24 hrs as inhibition of [3H]phenylalanine uptake2005Journal of natural products, Nov, Volume: 68, Issue:11
Structure and absolute configuration of nyasol and hinokiresinol via synthesis and vibrational circular dichroism spectroscopy.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's11 (68.75)29.6817
2010's4 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.13 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]